Tyche Industries Ltd. (BSE: 532384) is a Hyderabad, Telangana-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹107 Cr, it ranks #3,210 by market cap among the 6,189 Indian listed companies on FinBizNet, and #69 of 86 in Medicinal Chemicals and Botanical Products. At ₹104.20 (as of 26 Oct 2026), the share price is 29.6% below its 52-week high of ₹148.00 and 5.3% above its 52-week low of ₹99.00. The share price is down 25.0% over one year and down 17.6% over three months.
| Current Price | ₹104.20 |
|---|---|
| Market Cap | ₹107 Cr |
| BSE Code | 532384 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 15.6 |
| Return on Equity | 5.01% |
| Return on Assets | 0.33% |
| 52-Week Range | ₹99.00 – ₹148.00 |
| 1-Year Price Change | -25.0% |
| 3-Month Price Change | -17.6% |
| Beta (1Y) | 0.49 |
| Dividend Yield | 3.36% |
| Headquarters | Hyderabad, Telangana |
| Website | www.tycheindustries.net |
Tyche Industries Limited manufactures and sells active pharmaceutical ingredients and intermediates in India and internationally. The company also provides chiral intermediates and nutraceuticals; and contract drug substance and analytical development, as well as contract development, manufacturing, and analytical development services. It primarily exports its products to the United States and Europe. Tyche Industries Limited was incorporated in 1998 and is based in Hyderabad, India.
1. Pharmaceuticals-This segment manufactures and sells active pharmaceutical ingredients and intermediates.
1. APIs-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,19,404 Cr | 36.6 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,658 Cr | 22.5 | 18.32% | ₹8,017 Cr | +14.7% |
| Cipla Limited | ₹1,08,090 Cr | 27.9 | 11.74% | ₹7,119 Cr | -14.7% |
| Laurus Labs Ltd | ₹1,06,442 Cr | 119.8 | 17.74% | ₹2,026 Cr | +125.7% |
| Dr.Reddys Lab | ₹1,02,010 Cr | 23.8 | 11.52% | ₹8,698 Cr | -0.9% |
| Mankind Pharma | ₹91,379 Cr | 47.8 | 12.45% | ₹4,031 Cr | -9.9% |
| Aurobindo Pharma Ltd. | ₹90,432 Cr | 26 | 9.93% | ₹9,150 Cr | +41.7% |
| Lupin Ltd | ₹88,018 Cr | 16.5 | 26.91% | ₹8,277 Cr | -1.1% |
| Tyche Industries Ltd. | ₹107 Cr | 15.6 | 5.01% | — | -25.0% |
Listed by market capitalisation. Ratios are shown for context only.
Tyche Industries Ltd. is trading at ₹104.20, with a market capitalisation of ₹107 Cr.
Tyche Industries Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Tyche Industries Ltd. has a P/E of 15.6 and a return on equity of 5.01%.
Tyche Industries Ltd. is listed on the BSE under the scrip code 532384.
Tyche Industries Ltd.'s share price is down 25.0% over one year and down 17.6% over three months. Its 52-week range is ₹99.00 to ₹148.00.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.